寶島科

-0.70 (-0.77%)最後更新 2026-09-11

台灣 · 上櫃 · 生技醫療業

89.8020成交張數12.27本益比1.26股價淨值比7.24%殖利率2026-09-11資料日期

ROE 與 ROA

近四季合計;近十年

每股淨值

元

負債比率

負債總額 / 資產總額

現金流量

單季,億元;自由現金流 = 營業現金流 + 資本支出(負值)

季度	資產總額(億)	母公司權益(億)	負債比率	流動比率	每股淨值	ROE(近四季)	ROA(近四季)	營業現金流(億)	自由現金流(億)
2026Q2	100	43	57.0%	1.66	71.37	12.0%	4.8%	1.2	0.8
2026Q1	92	39	58.0%	1.60	64.45	9.5%	4.0%	2.9	2.5
2025Q4	92	37	59.3%	1.56	62.08	10.7%	4.5%	3.2	2.2
2025Q3	88	35	60.4%	1.51	58.01	12.3%	5.1%	1.5	0.9
2025Q2	82	30	63.0%	1.42	50.67	13.2%	5.1%	0.9	0.3
2025Q1	83	36	56.6%	1.68	59.94	13.9%	6.0%	2.8	2.1
2024Q4	80	35	56.5%	1.68	57.82	15.4%	6.5%	2.7	2.2
2024Q3	77	33	57.1%	1.62	55.15	16.3%	6.9%	1.1	0.5
2024Q2	78	32	59.3%	1.57	52.76	16.0%	6.5%	1.3	0.6
2024Q1	75	32	57.3%	1.68	53.23	14.7%	6.3%	3.1	2.6
2023Q4	71	30	58.5%	1.64	49.25	15.1%	6.2%	1.7	0.4
2023Q3	68	28	58.5%	1.65	46.66	13.1%	5.4%	2.2	1.8
2023Q2	65	27	59.0%	1.59	44.49	12.4%	5.3%	1.4	1.0
2023Q1	65	28	56.6%	1.67	46.87	8.0%	3.6%	3.7	3.5
2022Q4	63	26	59.1%	1.57	43.17	6.5%	2.8%	2.0	1.6
2022Q3	62	25	59.3%	1.54	42.29	10.3%	4.3%	1.7	1.5
2022Q2	59	26	55.8%	1.57	43.23	9.0%	4.1%	0.1	-0.2
2022Q1	60	28	52.8%	0.75	47.14	10.1%	4.7%	3.1	2.9
2021Q4	57	26	53.8%	0.74	44.08	11.1%	5.1%	4.7	4.2
2021Q3	56	25	55.5%	0.70	41.42	11.3%	5.0%	1.2	1.0
2021Q2	57	27	52.6%	0.79	44.54	12.4%	5.6%	-0.9	-1.3
2021Q1	57	27	53.4%	0.72	44.45	12.6%	5.9%	1.8	1.7
2020Q4	57	26	54.0%	0.69	43.30	12.0%	5.6%	1.9	1.5
2020Q3	57	25	56.5%	0.67	40.95	13.6%	6.0%	2.6	2.2
2020Q2	55	23	57.2%	0.63	38.94	13.6%	5.9%	0.1	-0.8
2020Q1	54	26	52.1%	0.74	42.54	14.2%	6.7%	1.8	1.4
2019Q4	53	25	52.5%	0.86	42.07	15.5%	7.8%	1.2	1.0
2019Q3	53	24	54.5%	0.86	39.98	14.0%	6.8%	3.1	2.8
2019Q2	53	24	55.7%	0.82	39.22	13.2%	6.2%	-0.1	-0.5
2019Q1	54	25	53.1%	0.94	41.80	12.0%	6.0%	2.1	1.6
2018Q4	44	24	46.2%	1.15	39.52	10.8%	5.9%	0.8	0.5
2018Q3	42	23	46.6%	1.13	37.52	10.3%	5.5%	1.8	1.6
2018Q2	45	22	49.7%	1.11	37.38	11.7%	5.9%	0.4	0.2
2018Q1	44	24	45.5%	1.21	40.09	9.9%	5.4%	1.6	1.5
2017Q4	42	23	45.2%	1.16	38.46	13.2%	7.2%	0.2	0.0
2017Q3	42	23	46.2%	1.12	37.47	13.5%	7.2%	2.4	2.2
2017Q2	42	22	48.7%	1.13	35.96	14.9%	7.6%	0.2	-0.0
2017Q1	43	23	45.3%	1.24	38.46	15.5%	8.4%	1.1	0.8
2016Q4	43	23	45.9%	1.21	38.04	–	–	0.3	-0.1
2016Q3	42	22	46.6%	1.19	37.19	–	–	1.9	1.7